Vasculostatic agents and methods of use thereof
CA 2500727 A1 · Owner: Dneprovskaia, Elena · Inventors: Noronha, Glenn; Dneprovskaia, Elena; Wrasidlo, Wolfgang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods and are provided for treating disorders associated with compromised vasculostasis. Invention methods and compositions are useful for treating a variety of disorders including for example stroke, myocardial , infarction, cancer ischemia/reperfusion injury, autoimmune diseases such as rheumatoid arthritis, eye diseases such as retinopathies or macular degeneration or other vitreoretinal diseases inflammatory diseases, vascular , leakage syndrome edema, transplant rejection, adult/acute respiratory distress syndrome (ARDS), and the like.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 2, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.